The goal was to support post-cycle therapy (PCT) by blocking estrogen receptors and assisting hormonal recovery in combination with Enclomiphene.
How did you use this product?
How did you use this product?
Week 1: 30 mg daily
Week 2: 15 mg daily
Weeks 3–5: 7.5 mg daily (half tablet)
Used together with Enclomiphene as part of a structured PCT protocol.
Total duration of use
5 Weeks
Did you stack it with other compounds?
Currently combined with Enclomiphene, HGH, and Levocarnitine to optimize recovery, hormonal balance, and training performance during PCT.
Results & effectiveness
What changes did you notice while using this product?
It supported hormonal stabilization during PCT and contributed to a smooth transition off-cycle.
Mood and overall well-being remained stable.
How soon did you start noticing effects?
Within the first 1–2 weeks, with progressive stabilization over time.
How did the results compare to your expectations?
It performed as expected and complemented Enclomiphene well. The tapering approach worked smoothly.
Side effects & tolerance
Did you experience any side effects or negative changes?
Good overall, but the joint dryness should be considered, especially for individuals training with high intensity or volume.
Injection pain / discomfort (if applicable)
Not applicable (oral administration).
Overall tolerance
Good. Well tolerated at the chosen tapered dosages.
Final thoughts
Would you use this product again? Why or why not?
Yes. It worked well as part of a structured PCT protocol.
Would you recommend this product to others?
For individuals running proper post-cycle therapy and monitoring bloodwork, it can be a useful component.
Who is this product best suited for?
Users aiming for structured hormonal recovery after a suppressive cycle.
Additional comment
The tapered dosing approach (30 → 15 → 7.5 mg) felt smooth and helped maintain stability during PCT. Bloodwork will be included in the full cycle documentation.